Senior Resident, Department of Biochemistry, Lady Hardinge Medical College and associated hospitals, New Delhi, India
MD Amita Yadav
Department of Biochemistry, Lady Hardinge Medical College and associated hospitals, New Delhi, India
Sarika Arora
Department of Biochemistry, Lady Hardinge Medical College and associated hospitals, New Delhi, India
Ritu Singh
Department of Biochemistry, Lady Hardinge Medical College and associated hospitals, New Delhi, India
Jayashree Bhattacharjee
Department of Biochemistry, Lady Hardinge Medical College and associated hospitals, New Delhi, India
Main Article Content
Association between different degrees of hypothyroidism and serum lipids
Vandana Saini
MD Amita Yadav
Sarika Arora
Ritu Singh
Jayashree Bhattacharjee
Abstract
The association between overt hypothyroidism (OH) and altered lipid profile is well known, however the significance of dyslipidemia in subclinical hypothyroidism (SCH) remain controversial. Therefore, this study was conducted to determine any association between lipid profile and different degrees of thyroid dysfunction. Thyroid and lipid profile parameters were analysed in 58 patients with overt (TSH ≥ 10.0 μIU/L and/or abnormally low fT4 and fT3 levels) and 87 patients with subclinical hypothyroidism (TSH 6.0-9.9 μIU/L with normal fT4 and fT3 levels) in this case-control study. These were compared with 100 age- and sex-matched euthyroid controls. It was found that only mean serum level of total cholesterol in patients with SCH was significantly high from that in controls (p=0.045). Other lipid parameters did not show any statistical significance. Whereas patients with OH had statistically significant higher levels of total cholesterol (p<0.001), triglyceride (p<0.05), LDL-C (p<0.001) and VLDL-C (p<0.05). There was also an increase in HDL-C in both SCH and OH group though not significant statistically. In conclusion, lipid profile is not much deranged in SCH whereas OH is a major cause of secondary dyslipidemia which may lead to increased risk of coronary artery disease. Therefore, thyroid hormone replacement would be most beneficial in patients with OH instead of SCH. However, patients with SCH should be monitored for deterioration of thyroid function and dyslipidemia at regular intervals.
Internet Journal of Medical Update 2012 July;7(2):3-8
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.